MENU
RNAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cartesian Therapeutics (RNAC) Ownership - Who owns Cartesian Therapeutics?
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
247.6M
P/E Ratio
1.86
Total Cash
180.43M
Projected Growth
N/A
Total Debt
14.07M
Revenue
34.17M
Risk (Beta)
0.16
Dividend Yield
N/A
Total Cash/Share
6.95
Total Debt/Equity
N/A
Revenue/Share
1.52 USD as % of share price
Fundamentals
RNAC
Capitalization
248M
P/E Ratio
1.86
Risk (Beta)
0.16
Dividend Yield
N/A
Total Cash
180M
Total Cash/Share
6.95
Total Debt
14.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.52%
Revenue
34.2M
ROE
N/A
Book Value
-21.79M
P/B Ratio
588.24
Cash Flow
N/A
Earnings
5.34
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
12.34
Current Revenue Per Employee
16666.67
Dividends Per Share - Security
N/A
EBITDA
-83.55M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-10.43
Shares Held By Institutions
177M
Shares Outstanding - Current
26M
Total Liabilities
431M
Total Volume MTD
N/A
Value
-1
Gain YTD
-46.734
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of targeted immunotherapies and vaccines to treat and prevent diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com